CQR-300
Commercial- Indications
- Weight management, Metabolic disorders
Company intelligence / Profile preview
Gateway Health Alliances develops and supplies patented, clinically validated natural ingredients for weight management, metabolic wellness, cardiovascular health, and sleep. Their lead products—Dyglomera®/DygloFit® (Dichrostachys glomerata extract), CQR‑300® (Cissus quadrangularis extract), Somnoril™ (for sleep), and IGOB131 (Irvingia gabonensis extract)—have demonstrated significant improvements in GLP‑1 levels, body weight reduction (~14–17%), improved metabolic biomarkers, and other benefits across more than 10 clinical studies involving over 1000 subjects. These ingredients are used by food/beverage/supplement manufacturers globally.
4 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gateway Health Alliances.